门干预后并发症的管理
Agam Bansal1, Rishi Puri1, James Yun1
1Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
概括
过导管干预措施为患有膜心脏病的高风险患者提供了更好的结果. 本综述详细介绍了跨导管大动脉植入和中枢修复/更换的并发症,预防和治疗方法.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 过导管干预 (TVI) 对高风险手术患者的膜心脏病管理进行了革命.
- 越来越多的利用需要全面了解潜在的并发症.
- 熟悉罕见并发症及其管理对于最佳患者结果至关重要.
研究的目的:
- 提供与关键跨导管干预相关的并发症的最新审查.
- 概述预防和管理这些并发症的策略.
- 涵盖过导管大动脉植入 (TAVI),中导管过导管边缘到边缘修复 (M-TEER) 和中导管中导替换 (TMVR).
主要方法:
- 对TAVI,M-TEER和TMVR后并发症的系统文献综述.
- 综合当前关于并发症发生率,机制和临床影响的证据.
- 专家就预防和管理的最佳实践达成共识.
主要成果:
- 并发症因手术不同而有所不同,但可能包括血管接入问题,心脏栓塞,器件错位和副膜泄漏.
- 早期识别和适当管理是缓解不良事件的关键.
- 预防策略包括仔细选择患者,程序规划和先进的成像.
结论:
- 过导管干预需要对潜在并发症进行警监测.
- 有效的预防和管理策略对于成功的TAVI,M-TEER和TMVR至关重要.
- 本综述是临床医生管理那些接受这些先进心脏手术的患者的关键资源.
相关概念视频
Heart Valves
3.8K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
3.8K
Esophageal Varices-II: Clinical Features and Management
24
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
24
Pneumonia III: Complications and Assessment
117
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
117
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305


